Lixia Yu

945 total citations
39 papers, 716 citations indexed

About

Lixia Yu is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, Lixia Yu has authored 39 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 10 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Lixia Yu's work include Parathyroid Disorders and Treatments (11 papers), Chronic Kidney Disease and Diabetes (9 papers) and Dialysis and Renal Disease Management (8 papers). Lixia Yu is often cited by papers focused on Parathyroid Disorders and Treatments (11 papers), Chronic Kidney Disease and Diabetes (9 papers) and Dialysis and Renal Disease Management (8 papers). Lixia Yu collaborates with scholars based in China, Germany and United States. Lixia Yu's co-authors include Qifeng Liu, Shasha Li, Jianming Ye, Wen‐Jing Hu, Jing Sun, Xiaoping Qian, Jianhua Feng, Xiaohong Dong, Xiaoxia Gu and Xiaohua Tan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Nutrients and Metabolism.

In The Last Decade

Lixia Yu

34 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixia Yu China 20 336 266 103 83 80 39 716
Wenjun Lin China 16 216 0.6× 376 1.4× 86 0.8× 75 0.9× 47 0.6× 43 750
Lirong Hao China 17 199 0.6× 287 1.1× 86 0.8× 91 1.1× 57 0.7× 34 763
Krishna R. Polu United States 9 551 1.6× 319 1.2× 94 0.9× 62 0.7× 87 1.1× 17 907
Masahiko Kushiro Japan 10 231 0.7× 121 0.5× 52 0.5× 65 0.8× 60 0.8× 13 675
Kevin B. Atkins United States 17 158 0.5× 439 1.7× 79 0.8× 109 1.3× 48 0.6× 23 890
Jili Zhu China 10 299 0.9× 244 0.9× 88 0.9× 54 0.7× 62 0.8× 19 595
Minseob Eom South Korea 14 104 0.3× 352 1.3× 69 0.7× 89 1.1× 50 0.6× 45 797
Congwei Luo China 16 272 0.8× 529 2.0× 50 0.5× 113 1.4× 77 1.0× 22 1.0k
Steven Radoff United States 11 306 0.9× 264 1.0× 97 0.9× 105 1.3× 180 2.3× 15 1.5k
Chi Liu China 15 162 0.5× 411 1.5× 61 0.6× 77 0.9× 42 0.5× 39 834

Countries citing papers authored by Lixia Yu

Since Specialization
Citations

This map shows the geographic impact of Lixia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Yu more than expected).

Fields of papers citing papers by Lixia Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Yu. The network helps show where Lixia Yu may publish in the future.

Co-authorship network of co-authors of Lixia Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lixia Yu. A scholar is included among the top collaborators of Lixia Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixia Yu. Lixia Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Bei, et al.. (2025). Therapeutic Potential of hucMSC‐EVs in Diabetic Kidney Disease via Regulating the miR‐146b‐5p/Merlin/YAP Axis. Stem Cells International. 2025(1). 5243270–5243270.
2.
Yu, Lixia, et al.. (2025). Easing Youth Career Distress: Impacts of Future Work Self Salience, Goal Engagement, and Calling Motivation. Journal of Career Development. 52(6). 818–836.
3.
4.
Yu, Lixia, et al.. (2024). Bridging the Gender Gap in Academic Engagement among Young Adults: The Role of Anticipated Future Sex Discrimination and Gender-role Orientation. Journal of Youth and Adolescence. 53(10). 2192–2201. 1 indexed citations
5.
Wang, Rui, Tieqiang Sun, Yuxian Zhang, et al.. (2024). Vitamin B6 alleviates chronic sleep deprivation-induced hippocampal ferroptosis through CBS/GSH/GPX4 pathway. Biomedicine & Pharmacotherapy. 174. 116547–116547. 12 indexed citations
6.
Li, Shasha, et al.. (2023). Upstream and downstream regulators of Klotho expression in chronic kidney disease. Metabolism. 142. 155530–155530. 36 indexed citations
7.
Li, Shasha, et al.. (2022). Abnormally decreased renal Klotho is linked to endoplasmic reticulum-associated degradation in mice. International Journal of Medical Sciences. 19(2). 321–330. 5 indexed citations
8.
Liu, Qifeng, et al.. (2021). Correlation Between Soluble Klotho and Vascular Calcification in Chronic Kidney Disease: A Meta-Analysis and Systematic Review. Frontiers in Physiology. 12. 711904–711904. 14 indexed citations
9.
Tan, Xiaohua, et al.. (2020). Fibroblast Growth Factor 10 Attenuates Renal Damage by Regulating Endoplasmic Reticulum Stress After Ischemia–Reperfusion Injury. Frontiers in Pharmacology. 11. 39–39. 20 indexed citations
10.
Liu, Qifeng, et al.. (2019). The Prognostic Role of Klotho in Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis. Disease Markers. 2019. 1–12. 26 indexed citations
11.
Yu, Lixia, Ling Li, Tingting Bai, et al.. (2018). Activation of autophagy contributes to the renoprotective effect of postconditioning on acute kidney injury and renal fibrosis. Biochemical and Biophysical Research Communications. 504(4). 641–646. 32 indexed citations
12.
Yu, Lixia, et al.. (2017). c-Maf inducing protein inhibits cofilin-1 activity and alters podocyte cytoskeleton organization. Molecular Medicine Reports. 16(4). 4955–4963. 8 indexed citations
13.
Liu, Qifeng, Jianming Ye, Lixia Yu, et al.. (2016). Klotho mitigates cyclosporine A (CsA)-induced epithelial–mesenchymal transition (EMT) and renal fibrosis in rats. International Urology and Nephrology. 49(2). 345–352. 33 indexed citations
14.
Li, Shasha, et al.. (2015). Ginsenoside-Rg1 inhibits endoplasmic reticulum stress-induced apoptosis after unilateral ureteral obstruction in rats. Renal Failure. 37(5). 890–895. 21 indexed citations
15.
Wang, Fang, Jie Ding, Hongwen Zhang, et al.. (2014). [Comparison of phenotypic features between patients with X-linked and autosomal recessive Alport syndrome].. PubMed. 46(2). 311–4. 1 indexed citations
16.
Yu, Lixia, Yanbo Liu, Yanfeng Wu, et al.. (2014). Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage. Cellular Signalling. 26(12). 2979–2991. 29 indexed citations
17.
Zhang, Yanqin, Fang Wang, Jie Ding, et al.. (2012). Genotype–phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome. American Journal of Medical Genetics Part A. 158A(9). 2188–2193. 24 indexed citations
18.
Yu, Lixia, Qiuxia Lin, Hua Liao, et al.. (2010). TGF-β1 Induces Podocyte Injury Through Smad3-ERK-NF-κB Pathway and Fyn-dependent TRPC6 phosphorylation. Cellular Physiology and Biochemistry. 26(6). 869–878. 38 indexed citations
19.
20.
Ding, Jie, et al.. (1997). Alport syndrome with neurofibromatosis type-I: a case report. Pediatric Nephrology. 11(5). 649–650. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026